Roger Gifford is a Principal Scientist and Pharmacologist at Pfizer, specializing in preclinical development of novel treatments for autoimmune diseases, particularly within rheumatology and neurodegeneration. They have significant experience in preclinical and in vivo pharmacology research, having previously worked at organizations such as Mass General Hospital and Resilience Therapeutics, where they focused on tissue processing and PTSD pharmacological treatments, respectively. Gifford holds a Master of Arts in Cognitive & Neural Systems from Boston University and a Master of Science in Pharmaceutical Sciences from Northeastern University, along with a Bachelor's degree in Philosophy and Neuroscience from Lawrence University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices